about
Circular RNAs: clinical relevance in cancer.The Antitumor Activities ofCommentary: Lico A causes ER stress and apoptosis via up-regulating miR-144-3p in human lung cancer cell line H292Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patientsThe effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancerA tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinomaRoles of highly expressed PAICS in lung adenocarcinomaFGFR2-mediated phosphorylation of PTEN at tyrosine 240 contributes to the radioresistance of gliomaComparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphismsComprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related GenesSIRT5 downregulation is associated with poor prognosis in glioblastomaMTHFR C677T polymorphism is associated with follicle-stimulating hormone levels and controlled ovarian hyperstimulation response: a retrospective study from the clinical databaseVitamin D supplementation and colorectal cancer prognosisLung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLCThe Impact of Patient Characteristics on Tumor Cell Program Death Ligand 1 Expression in Patients With NCSLCThe Roles of Plant-Derived Triptolide on Non-Small Cell Lung CancerCFHR1 is a potentially downregulated gene in lung adenocarcinomaFunction of low ADARB1 expression in lung adenocarcinomaExpression and clinical significance of CPS1 in glioblastoma multiformeCurrent perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities
P50
Q50128135-EC78A47F-05F7-42B7-BB79-BB991EEA4686Q58573348-04DAEC58-69EE-4ABE-968F-CC129EDCA177Q61807438-ED76DB5E-3C00-48B2-8C99-3803AA00F4C4Q64064706-CA458508-73E5-48FA-BB76-B1899F9EB44CQ64097202-157F2387-D538-4185-A6F2-5C3A839BBD1AQ64941546-F4133B6C-598A-47BC-94CF-DAB9781E2790Q90860604-3FB3D30B-9EFB-466D-B957-7AC9A863D495Q91037984-123EB73C-D286-4531-B8B4-6513ECE5CEFEQ91532787-5801597F-49AD-4A07-9183-7CF4E0ECF1D8Q92524238-804371CE-7FD3-40D7-80D0-61255CA8701FQ92557671-5F162C70-DE59-4C97-8238-DEF9DB7C9BC5Q92603222-29A3701B-0F01-40C7-8D62-36BCB0228B75Q92683553-C23D53B6-01B7-488B-B0AE-29D8E4037A27Q92691888-ACB7EFC5-76D5-4F83-9BD4-BC6E4A3B576EQ92843727-10A1DCC7-A906-4C5C-8557-9201344B8656Q92843761-4466F822-3940-4675-99CA-F3835398E6E0Q93079703-6FB9B87E-D954-4549-8EBD-F7A287F385D3Q93111200-A4005314-5F39-4E04-B7F0-5CC588ABE43BQ93147786-137F78AE-4B2B-438E-9047-12EE7F7BD3DDQ93160100-ADF1D639-8408-45DC-971D-8AB3BFCD432DQ96306609-D99478CB-E49E-43D0-945F-EE2AF294D8D8
P50
description
researcher
@en
name
Yuanliang Yan
@en
type
label
Yuanliang Yan
@en
prefLabel
Yuanliang Yan
@en
P31
P496
0000-0001-6610-3617